Parul Goyal, MD, FACP, associate professor of Medicine, was quoted in a HuffPost piece, “7 signs you’re aging well, according to geriatricians”
CBS News Radio and Medical Xpress interviewed Bill Heerman, MD, associate professor of Pediatrics, William K. Warren Foundation Chair in Medicine, and chief of the Division of Academic General Pediatrics, for a story about his study on youth obesity in the U.S.
Everyday Healthreporter Roxanne Nelson interviewed Jonathan Kropski, MD, professor of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, for a story about managing chronic fatigue with idiopathic pulmonary fibrosis (IPF).
William Schaffner, MD, professor of Preventive Medicine, was quoted by several news outlets about public health issues, including NBC News and WKRN News 2 (flu); Scientific American (mRNA vaccines); and MedicalResearch.com and ABC News (measles).
NewsChannel 5 “Open Line” featured Daniel Munoz, MD, executive medical director of the Vanderbilt Heart & Vascular Institute for its segment on heart month.
Xtelligent Healthcare senior editor Anuja Vaidya interviewed Colin Walsh, MD, associate professor of Biomedical Informatics, for a story about how health systems are training staff on AI-enabled clinician decision support tools.
Amy Brown, MD, assistant professor of Neurology, was interviewed by NBC Chicago reporter Courtney Sisk to discuss the passing of the Rev. Jesse Jackson due to complications of progressive supranuclear palsy (PSP). Brown leads Vanderbilt Health’s PSP Center of Excellence and is a top regional specialist for the disease.
Preventionreporter Korin Miller interviewed Qi Dai, MD, PhD, professor of Medicine, from the Vanderbilt Epidemiology Center, for a story about his Vanderbilt study that found taking a magnesium supplement can increase certain gut bacteria in people, which may ultimately lower the risk of colorectal cancer.
The Mountain Press, Ground News, and others are covering the Vanderbilt Health News press release about the Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary symptoms of Long COVID (REVERSE-LC) receiving additional funding from the National Institute of Allergy and Infectious Diseases (NIAID) program called RECOVER-Treating Long COVID (RECOVER-TLC) to expand the investigation by working with the NIA to add 13 more enrolling sites throughout the United States.
